Literature DB >> 20592872

The role of N53Q mutation on the rat mu-opioid receptor function.

A Rostami1, M Rabbani, M Mir-Mohammad-Sadeghi.   

Abstract

Glycosylation of the mu-opioid receptor may play an important role on its function. Using nested PCR, N53Q mutation was prepared in the N-terminal region of the rat mu-opioid receptor cDNA and cloned into the pcDNA3 vector. The plasmids containing the wild-type and mutated receptor cDNA were transfected into the COS-7 cells. Intracellular cAMP was measured in the morphine-treated and untreated transfected cells using an ELISA kit. Plasmid expression was evaluated using X-gal staining. Intracellular concentration of cAMP in the N53Q-mutated cells was not significantly different from the wild-type. The expression of the transfected plasmids was confirmed. Therefore, based on these results, it seems that glycosylation at the N53 site of the rat mu-opioid receptor does not influence the function of this receptor significantly.

Entities:  

Keywords:  cAMP; glycosylation

Mesh:

Substances:

Year:  2010        PMID: 20592872      PMCID: PMC2884312     

Source DB:  PubMed          Journal:  J Biomol Tech        ISSN: 1524-0215


  28 in total

1.  Glycosylation affects agonist binding and signal transduction of the rat somatostatin receptor subtype 3.

Authors:  R B Nehring; D Richter; W Meyerhof
Journal:  J Physiol Paris       Date:  2000 May-Aug

2.  G(z) can mediate the acute actions of mu- and kappa-opioids but is not involved in opioid-induced adenylyl cyclase supersensitization.

Authors:  P H Tso; Y H Wong
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

3.  Glycosylation of the gastrin-releasing peptide receptor and its effect on expression, G protein coupling, and receptor modulatory processes.

Authors:  R V Benya; T Kusui; T Katsuno; T Tsuda; S A Mantey; J F Battey; R T Jensen
Journal:  Mol Pharmacol       Date:  2000-12       Impact factor: 4.436

4.  Identification of the sites of asparagine-linked glycosylation on the human thyrotropin receptor and studies on their role in receptor function and expression.

Authors:  Y Nagayama; E Nishihara; H Namba; S Yamashita; M Niwa
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

5.  N-glycosylation of CRF receptor type 1 is important for its ligand-specific interaction.

Authors:  I Q Assil; A B Abou-Samra
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-11       Impact factor: 4.310

6.  Effect of N-glycosylation on ligand binding affinity of rat V1a vasopressin receptor.

Authors:  K H Lee; J I Ahn; D H Yu; H S Jeong; S H Lee; K S Kim; I Y Chung; J H Kim; Y S Lee
Journal:  Biochem Biophys Res Commun       Date:  2001-08-31       Impact factor: 3.575

7.  mu Opioid receptor: role for the amino terminus as a determinant of ligand binding affinity.

Authors:  K Chaturvedi; M Shahrestanifar; R D Howells
Journal:  Brain Res Mol Brain Res       Date:  2000-03-10

8.  Export from the endoplasmic reticulum represents the limiting step in the maturation and cell surface expression of the human delta opioid receptor.

Authors:  U E Petaja-Repo; M Hogue; A Laperriere; P Walker; M Bouvier
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

9.  Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction.

Authors:  Z Zhang; S C Austin; E M Smyth
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

10.  A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling.

Authors:  K Befort; D Filliol; F M Decaillot; C Gaveriaux-Ruff; M R Hoehe; B L Kieffer
Journal:  J Biol Chem       Date:  2000-11-06       Impact factor: 5.157

View more
  1 in total

Review 1.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.